scholarly article | Q13442814 |
P2093 | author name string | R C Craven | |
T M Cairns | |||
P2860 | cites work | RNA dimerization defect in a Rous sarcoma virus matrix mutant | Q24524289 |
Sequence and transcriptional analyses of the fish retroviruses walleye epidermal hyperplasia virus types 1 and 2: evidence for a gene duplication. | Q24527316 | ||
Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution | Q27617655 | ||
Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses | Q27621316 | ||
Structure and self-association of the Rous sarcoma virus capsid protein | Q27625128 | ||
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein | Q27746461 | ||
Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26 | Q27766867 | ||
Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A | Q28379060 | ||
Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
Shared motifs of the capsid proteins of hepadnaviruses and retroviruses suggest a common evolutionary origin. | Q30176081 | ||
Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation | Q30452616 | ||
Sequence comparisons of retroviral proteins: relative rates of change and general phylogeny | Q33566284 | ||
Genetic determinants of Rous sarcoma virus particle size. | Q33782075 | ||
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. | Q33822095 | ||
Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. | Q33911943 | ||
Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein | Q35841323 | ||
The membrane-binding domain of the Rous sarcoma virus Gag protein | Q35859598 | ||
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription | Q35861172 | ||
Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein | Q35886606 | ||
Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis | Q36556895 | ||
Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus | Q36591119 | ||
Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. | Q36624411 | ||
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions | Q36624873 | ||
Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein | Q36653886 | ||
Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins | Q36654259 | ||
Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis | Q36686708 | ||
Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage | Q36690518 | ||
Positional cloning of the mouse retrovirus restriction gene Fv1. | Q36812909 | ||
Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly | Q36821952 | ||
Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells | Q36831122 | ||
Reversal of Fv-1 host range by in vitro restriction endonuclease fragment exchange between molecular clones of N-tropic and B-tropic murine leukemia virus genomes | Q36908685 | ||
Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses | Q36910235 | ||
Mutations in the Ty3 major homology region affect multiple steps in Ty3 retrotransposition. | Q39874527 | ||
Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release | Q40047075 | ||
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro | Q40067568 | ||
Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus | Q40127690 | ||
Dynamic interactions of the Gag polyprotein | Q41100814 | ||
Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection | Q41174834 | ||
A conformational switch controlling HIV-1 morphogenesis | Q42690194 | ||
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail | Q42799744 | ||
Solution structure of the capsid protein from the human T-cell leukemia virus type-I. | Q45747944 | ||
The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo | Q45764495 | ||
Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures | Q45826793 | ||
Evolution of retroposons by acquisition or deletion of retrovirus-like genes | Q46084667 | ||
A nucleoprotein complex mediates the integration of retroviral DNA. | Q46128219 | ||
The major homology region of the HIV-1 gag precursor influences membrane affinity. | Q52522369 | ||
Structure of the amino-terminal core domain of the HIV-1 capsid protein | Q71142552 | ||
P433 | issue | 1 | |
P921 | main subject | Rous sarcoma virus | Q1444330 |
P304 | page(s) | 242-250 | |
P577 | publication date | 2001-01-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants. | |
P478 | volume | 75 |
Q34975957 | A long terminal repeat-containing retrotransposon of Schizosaccharomyces pombe expresses a Gag-like protein that assembles into virus-like particles which mediate reverse transcription. |
Q35750243 | A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein |
Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
Q35920838 | Atomic Modeling of an Immature Retroviral Lattice Using Molecular Dynamics and Mutagenesis |
Q45428884 | Blocking HIV-1 virus assembly |
Q37252303 | Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins |
Q35019967 | Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination |
Q36950909 | Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly |
Q36283603 | Control of viral infectivity by tripartite motif proteins. |
Q33707470 | Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication |
Q36776033 | Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid |
Q36673166 | Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. |
Q34019412 | Element-specific localization of Drosophila retrotransposon Gag proteins occurs in both nucleus and cytoplasm |
Q34364648 | Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication |
Q39748566 | Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein |
Q35635221 | Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. |
Q37060306 | Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants Containing Cores with Abnormally High Levels of Capsid Protein and Virtually No Reverse Transcriptase |
Q33845811 | Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells |
Q37682781 | Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication. |
Q34485584 | Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways |
Q40823351 | Lethal mutations in the major homology region and their suppressors act by modulating the dimerization of the rous sarcoma virus capsid protein C-terminal domain |
Q38812540 | Mutations of Conserved Residues in the Major Homology Region Arrest Assembling HIV-1 Gag as a Membrane-Targeted Intermediate Containing Genomic RNA and Cellular Proteins |
Q33743971 | Potential role for CA-SP in nucleating retroviral capsid maturation |
Q36496940 | RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. |
Q34337314 | Reconstitution of retroviral fusion and uncoating in a cell-free system |
Q41244531 | Retroviral capsid assembly: a role for the CA dimer in initiation |
Q33844210 | Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions |
Q45723200 | Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection. |
Q28485054 | Structural and functional insights into the HIV-1 maturation inhibitor binding pocket |
Q33567553 | Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study |
Q36543685 | The maturational refolding of the β-hairpin motif of equine infectious anemia virus capsid protein extends its helix α1 at capsid assembly locus |
Q44525735 | Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. |
Q27931343 | Ty3 capsid mutations reveal early and late functions of the amino-terminal domain |
Q39317949 | Ubiquitin enzymes in the regulation of immune responses |
Q40619175 | VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability. |
Search more.